| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/11/2007 | CN1325650C Delivery system for porcine somatotropin |
| 07/11/2007 | CN1325649C Gene recombinant human cytomegalovirus fusion protein pp150/MDBP, preparation process and application thereof |
| 07/11/2007 | CN1325645C Histamine and serotonin binding molecules |
| 07/11/2007 | CN1325644C Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 07/11/2007 | CN1325643C Oligonucleotides modulating expression of enzymes involved in synthesis of melanic pigments |
| 07/11/2007 | CN1325639C Preparation method for high purity lumbrukinase and pharmaceutical preparation made therefrom |
| 07/11/2007 | CN1325514C Scorpion pain-stopping anti-tumor Val-Arg-Gly peptide and its preparation method |
| 07/11/2007 | CN1325118C Ion composite type water-soluble pharmaceutical compositions, and use thereof |
| 07/11/2007 | CN1325116C Pharmaceutical preparation of recombinant factor VIII lyophilized without albumin as a stabilizer |
| 07/11/2007 | CN1325115C Methods for CTL and T helper cell in therapeutic vaccination |
| 07/11/2007 | CN1325114C Novel purpose of L-alanyl-L-glutamine dipeptide |
| 07/11/2007 | CN1325046C Biodegradable polymeric nanocapsules and uses thereof |
| 07/11/2007 | CN1324986C Health-care product and preparing method |
| 07/10/2007 | US7242479 Gas sensors |
| 07/10/2007 | US7241877 Humanised antibodies |
| 07/10/2007 | US7241876 Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/10/2007 | US7241871 Method and process for the production of collagen preparations from invertebrate marine animals and compositions thereof |
| 07/10/2007 | US7241870 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 07/10/2007 | US7241869 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 07/10/2007 | US7241867 Polypeptide encoded by a nucleotide sequence of a nontypeable strain of Haemophilus influenzae genome |
| 07/10/2007 | US7241863 Comprises calcium/glutamate receptor chimera comprising extracellular domain of G-protein coupled membrane protein for treating nervous system disorders |
| 07/10/2007 | US7241862 Polypeptides that induce cell proliferation or induce fetal hemoglobin |
| 07/10/2007 | US7241861 High density lipoprotein-reactive peptides |
| 07/10/2007 | US7241860 Transcription factor polypeptide that regulates Chondromodulin-I expression |
| 07/10/2007 | US7241796 Peptidomimetic compounds |
| 07/10/2007 | US7241744 Delivering into cells of the subject an effective amount of a nucleic acid expression construct that encodes a growth-hormone-releasing-hormone ("GHRH") or functional biological equivalent thereof for therapy of anemia |
| 07/10/2007 | US7241742 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferative disorders |
| 07/10/2007 | US7241740 Peptides as solubilizing excipients for transforming growth factor beta proteins |
| 07/10/2007 | US7241739 Contacting Bone Morphogenic Protein with human Cerberus protein to antagonize the function of a Bone Moarphogenic Protein or induce neural development |
| 07/10/2007 | US7241738 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/10/2007 | US7241737 Urotensin-II agonists and antagonists |
| 07/10/2007 | US7241736 spider, silkworm or other silk as a fibrosing agent; induce adhesion or fibrosis in the walls of the diverticula or facilitate "filling" of the diverticula in situ; thus obliterating the lumen of the diverticula and relieving symptoms |
| 07/10/2007 | US7241733 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 07/10/2007 | US7241731 Oligopeptides for promoting hair growth |
| 07/10/2007 | US7241618 A polynucleotide comprising a RNA polymerase promoter, able encoding a siRNA; treating cancer and genetic disorders; genetic engineering, inhibit gene expression of a target gene |
| 07/10/2007 | US7241605 Polypeptide |
| 07/10/2007 | US7241595 Preparation of antiproliferative agent; obtain chemical intermediates, insert into reaction mixture, heat, remove protective groups, recover antiproliferative agent |
| 07/10/2007 | US7241593 Comprises fusion protein comprising platelet derived growth factor for treating connective tissue, tumor and bone disorders |
| 07/10/2007 | US7241591 Adenovirus comprising a gene coding for glutathione peroxidase |
| 07/10/2007 | US7241581 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a c-MYC protein |
| 07/10/2007 | US7241580 Immunoaffinity chromatography using epitope tags to polyol-responsive monoclonal antibodies |
| 07/10/2007 | US7241577 Mullerian inhibiting substance levels and ovarian response |
| 07/10/2007 | US7241576 Applications of a novel cytokine, named THANK, for TNF homologue that activates apoptosis, NF- kappa B and c-jun N-terminal kinase. Such applications include using THANK inhibitors to inhibit the activation of NF-kappa B and to |
| 07/10/2007 | US7241571 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis |
| 07/10/2007 | US7241461 Compositions for alleviating inflammation and oxidative stress in a mammal |
| 07/10/2007 | US7241450 DNA sequence and recombinant production of a Gramineae allergen |
| 07/10/2007 | US7241449 Recombinant Tbp2 protein of Moraxella catarrhalis strain M35, 3 or LES1, used in diagnostics and in vaccines |
| 07/10/2007 | US7241448 T helper cell epitopes |
| 07/10/2007 | US7241446 Methods for modulating angiogenesis via VEGF |
| 07/10/2007 | US7241445 Human monoclonal antibody against hepatitis C virus E2 glycoprotein |
| 07/10/2007 | US7241442 On membranes such as macrophages; lysosome storage diseases; genetic engineering |
| 07/10/2007 | US7241440 Identifying a subject in need of an increase in titer of IgG antibodies that are specific for a viral antigen; providing an immunogenic composition comprising ribavirin and a nucleic acid molecule encoding viral antigen. |
| 07/10/2007 | US7241438 Interleukin protein for use as tool in identifying modulators of prevention and treatment of disorders associated with inflammatory response |
| 07/10/2007 | US7241282 Compositions and methods for prolonging survival of platelets |
| 07/10/2007 | CA2466340C Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical |
| 07/10/2007 | CA2380072C Nicotine in therapeutic angiogenesis and vasculogenesis |
| 07/10/2007 | CA2260756C System for genetically treating cardiac conduction disturbances |
| 07/10/2007 | CA2254835C Glycine transporter-transfected cells and uses thereof |
| 07/10/2007 | CA2238313C Thermolabile uracil-dna-glycosylase, process for its production and use for removing uracil from dna |
| 07/10/2007 | CA2203129C Creating an aerosolized formulation of insulin |
| 07/10/2007 | CA2200371C Human npik gene |
| 07/10/2007 | CA2173316C Local polymeric gel cellular therapy |
| 07/10/2007 | CA2162149C Antibodies to p-selectin and their uses |
| 07/10/2007 | CA2128706C Polyunsaturated fatty acid based drugs, in particular docosahexaenoic acid, as platelet aggregation inhibitors and against essential fatty acid deficiencies of the brain |
| 07/10/2007 | CA2124769C Recombinant foamy virus vectors for medicinal and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 07/10/2007 | CA2108466C Hcv genomic sequences for diagnostics and therapeutics |
| 07/10/2007 | CA2064604C Method for inhibiting pulmonary oxygen toxicity |
| 07/10/2007 | CA2060455C Reverse antimicrobial peptides, antimicrobial oligopeptides and other antimicrobial compositions, and methods of their production and use, particularly to provide protection against plant pathogens |
| 07/05/2007 | WO2007076505A2 Transferrin and transferrin-based compositions for diabetes treatment |
| 07/05/2007 | WO2007076371A2 Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same |
| 07/05/2007 | WO2007076354A2 Stable protein formulations |
| 07/05/2007 | WO2007076342A1 Use of parathyroid hormone for treating periodontal and for other dental applications |
| 07/05/2007 | WO2007076323A2 Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof |
| 07/05/2007 | WO2007076131A2 Compositions comprising polycation-complexed protein crystals and methods of treatment using them |
| 07/05/2007 | WO2007075912A2 A system and method of administering a therapeutic material to brain tissue |
| 07/05/2007 | WO2007075906A2 Improved thyroid-stimulating hormone receptor polypeptide agonist glycoforms to treat metabolic syndrome |
| 07/05/2007 | WO2007075899A2 Dual agonist compounds and uses thereof |
| 07/05/2007 | WO2007075853A2 Protease compositions for the treatment of damaged tissue |
| 07/05/2007 | WO2007075845A2 Isolated mcpip and methods of use |
| 07/05/2007 | WO2007075447A2 Compositions and methods for oxalate reduction |
| 07/05/2007 | WO2007075388A2 Methods of locally treating and preventing cardiac disorders |
| 07/05/2007 | WO2007075318A2 Agents that reduce apoe-induced impairment of mitochondria and methods of use thereof |
| 07/05/2007 | WO2007075199A1 Use of alkaline phosphatase to maintain healthy tissue mass in mammals |
| 07/05/2007 | WO2007075188A2 Methods for treating bacillus infection |
| 07/05/2007 | WO2007075120A1 Method for producing a stable aqueous solution of a product containing active substances and a product (variants) |
| 07/05/2007 | WO2007075119A1 Pharmaceutical composition for photodynamic therapy and a method for treating oncological diseases by using said composition |
| 07/05/2007 | WO2007075115A1 Hemostatic agent |
| 07/05/2007 | WO2007075016A1 Collagenase inhibitor containing poly-gamma-glutamic acid-vitamin c complex and use thereof |
| 07/05/2007 | WO2007074788A1 Anti-tumor agent and immunostimulating agent |
| 07/05/2007 | WO2007074727A1 Remedy for oral moniliasis |
| 07/05/2007 | WO2007074471A1 Anti hiv-1 active bacterial and baculovirus recombinant epap-1 |
| 07/05/2007 | WO2007074457A2 Histidine-containing diastereomeric peptides and uses thereof |
| 07/05/2007 | WO2007074456A2 Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids |
| 07/05/2007 | WO2007074200A1 Inhibitor of the uracil-dna glycosylase enzyme and uses thereof |
| 07/05/2007 | WO2007074198A1 Selective peptides that inhibit the biological activity of calcineurin |
| 07/05/2007 | WO2007074188A1 Novel t-helper antigenic determinant (thd) peptides |
| 07/05/2007 | WO2007074185A1 Antimicrobial cyclic peptides |
| 07/05/2007 | WO2007073706A2 Carbohydrate-mimetic peptides and use thereof in pharmaceutical formulations |
| 07/05/2007 | WO2007073704A1 Use of a topical composition containing epidermal growth factor (egf) for diabetic foot amputation prevention |
| 07/05/2007 | WO2007073703A1 Cytoprotective pharmaceutical combination which can be used in the prevention and treatment of systemic inflammatory response syndrome |